AVITA Medical (RCEL) Capital Leases (2018 - 2019)
AVITA Medical (RCEL) posted Capital Leases of $37865.4 for Q2 2019, down 62.77% on a QoQ basis from $101698.8 in Q2 2018, and down 62.77% year-over-year from $101698.8 in Q2 2018.
AVITA Medical (RCEL) Capital Leases (2018 - 2019) Analysis & Trends
AVITA Medical's Capital Leases history runs 2 years deep, the most recent figure standing at $37865.4 for Q2 2019.
- Quarterly Capital Leases fell 62.77% year-over-year to $37865.4 in Q2 2019, while the trailing twelve-month figure through Jun 2019 was $37865.4 (down 62.77% YoY) and the FY2019 annual result came in at $38681.8, down 62.87% from the prior year.
- Capital Leases was $37865.4 for Q2 2019 at AVITA Medical, down from $101698.8 in the prior quarter.
- Across five years, Capital Leases topped out at $101698.8 in Q2 2018 and bottomed at $37865.4 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | AVITA Medical | 140.94 Mn | 124.59 Mn | 14.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 37,865.43 |
| Jun 30, 2018 | 101,698.83 |